Literature DB >> 1899066

Triggered human mucosal T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cells.

R L Deem1, F Shanahan, S R Targan.   

Abstract

T cell activation can lead to local tissue injury in organ culture studies of human fetal jejunum, either directly through cytotoxicity or indirectly by the release of cytotoxic cytokines. The goal of this study was to establish in vitro whether cytotoxic cytokines can be released by isolated colonic T cells and what cytokine interactions are required for killing of human colonic epithelial cells. Cytokine-containing supernatants were induced by incubating unseparated lamina propria lymphocytes (LPL) or mucosal T cell subpopulations (separated by indirect panning) with anti-CD3 and/or K562 target cells for 18 h at 37 degrees C. Cytokines were measured by cytotoxicity assays using L929 (murine fibroblast) and HT-29 (human colonic tumour) lines as target cells in combination with blocking anti-cytokine antibodies. Supernatants derived from unseparated, CD4+ (greater than 95% pure) and CD8+ (greater than 90% pure) LPL were cytotoxic to L929 targets (350 U/ml, 230 U/ml and 100 U/ml tumour necrosis factor-alpha, respectively). All or nearly all of the cytotoxicity was due to the presence of tumour necrosis factor-alpha (little or no tumour necrosis factor-beta was detected). These same supernatants were cytotoxic (up to 32% lysis at 1/4 dilution) to HT-29 targets in a 48-h 111In release assay. Recombinant tumour necrosis factor-alpha and interferon-gamma alone produced minimal killing of HT-29, but together killed the HT-29 target cells. Anti-tumour necrosis factor-alpha or anti-interferon-gamma alone blocked killing of HT-29 target cells by LPL-derived supernatants, although anti-tumour necrosis factor-beta had no effect upon killing of HT-29. These results demonstrate that human LPL T cells, triggered by addition of anti-CD3 and target cells, produce tumour necrosis factor-alpha and interferon-gamma, both of which are required for optimal killing of HT-29. Simultaneous release of these cytokines in the vicinity of epithelial cells during immune responses could play an important role in the mucosal damage in chronic inflammatory states such as inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1899066      PMCID: PMC1535451          DOI: 10.1111/j.1365-2249.1991.tb05592.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor.

Authors:  P Duerksen-Hughes; W S Wold; L R Gooding
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

2.  CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.

Authors:  C B Thompson; T Lindsten; J A Ledbetter; S L Kunkel; H A Young; S G Emerson; J M Leiden; C H June
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

Review 3.  The role of the T3/antigen receptor complex in T-cell activation.

Authors:  A Weiss; J Imboden; K Hardy; B Manger; C Terhorst; J Stobo
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

Review 4.  Immunologic mechanisms in intestinal diseases.

Authors:  S R Targan; M F Kagnoff; M D Brogan; F Shanahan
Journal:  Ann Intern Med       Date:  1987-06       Impact factor: 25.391

5.  Human mucosal cytotoxic effector cells.

Authors:  F Shanahan; M Brogan; S Targan
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682

6.  Human mucosal T-cell cytotoxicity.

Authors:  F Shanahan; R Deem; R Nayersina; B Leman; S Targan
Journal:  Gastroenterology       Date:  1988-04       Impact factor: 22.682

7.  Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3.

Authors:  M Steffen; O G Ottmann; M A Moore
Journal:  J Immunol       Date:  1988-04-15       Impact factor: 5.422

8.  Possible role for a human adenovirus in the pathogenesis of celiac disease.

Authors:  M F Kagnoff; R K Austin; J J Hubert; J E Bernardin; D D Kasarda
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

9.  Tumor necrosis factor identified in multiple sclerosis brain.

Authors:  F M Hofman; D R Hinton; K Johnson; J E Merrill
Journal:  J Exp Med       Date:  1989-08-01       Impact factor: 14.307

10.  Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens, and antigens.

Authors:  T Hara; L K Jung; J M Bjorndahl; S M Fu
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

View more
  43 in total

1.  Activation of lamina propria T cells induces crypt epithelial proliferation and goblet cell depletion in cultured human fetal colon.

Authors:  C M Evans; A D Phillips; J A Walker-Smith; T T MacDonald
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

2.  Characterization of a spontaneously polarizing HT-29 cell line, HT-29/cl.f8.

Authors:  Deanne M Mitchell; Judith M Ball
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Nov-Dec       Impact factor: 2.416

Review 3.  Production of inflammatory cytokines in the intestinal lamina propria.

Authors:  C Fiocchi
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

4.  Cytokine production by intestinal intraepithelial lymphocyte subsets in celiac disease.

Authors:  Francisco León; Laura Sánchez; Cristina Camarero; Garbiñe Roy
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

Review 5.  Role of mucosal T-cell-generated cytokines in epithelial cell injury.

Authors:  S R Targan; R L Deem; F Shanahan
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

6.  Immuno-epithelial interactions: cytokine modulation of normal rabbit colonocyte function.

Authors:  A Vidrich; P A Anton; F Shanahan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998 Nov-Dec       Impact factor: 2.416

7.  Natural killer cell activity in coeliac disease: effect of in vitro treatment on effector lymphocytes and/or target lymphoblastoid, myeloid and epithelial cell lines with gliadin.

Authors:  M A Castany; H H Nguyen; M Pospísil; P Fric; H Tlaskalová-Hogenová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

8.  Changes in barrier function of a model intestinal epithelium by intraepithelial lymphocytes require new protein synthesis by epithelial cells.

Authors:  C T Taylor; A Murphy; D Kelleher; A W Baird
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

9.  Interleukin 2 and interferon-gamma augment anticolon antibody dependent cellular cytotoxicity in ulcerative colitis.

Authors:  T Hibi; M Ohara; M Watanabe; T Kanai; H Takaishi; A Hayashi; Y Hosoda; H Ogata; Y Iwao; S Aiso
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

10.  Growth inhibition of a colonic adenocarcinoma cell line (HT29) by T cells specific for mutant p21 ras.

Authors:  T Gedde-Dahl; E Nilsen; E Thorsby; G Gaudernack
Journal:  Cancer Immunol Immunother       Date:  1994-02       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.